Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.412 EUR | -1.10% |
|
+6.49% | -27.71% |
06-24 | Valneva's Chikungunya Vaccine Receives Health Canada's Approval | MT |
06-24 | Valneva rises after Canadian approval for its chikungunya vaccine | RE |
Evolution of the average Target Price on Valneva
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Valneva
HC Wainwright | |
Goldman Sachs | |
Kepler Cheuvreux | |
Guggenheim | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- VLA Stock
- Consensus Valneva